These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database. Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397 [TBL] [Abstract][Full Text] [Related]
8. Polymyalgia rheumatica and risk of cerebrovascular accident: A systematic review and meta-analysis. Ungprasert P; Srivali N; Thongprayoon C Neurol India; 2016; 64(5):906-11. PubMed ID: 27625227 [TBL] [Abstract][Full Text] [Related]
9. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960 [TBL] [Abstract][Full Text] [Related]
13. Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms. Pego-Reigosa JM; Rodriguez-Rodriguez M; Hurtado-Hernandez Z; Gromaz-Martin J; Taboas-Rodriguez D; Millan-Cachinero C; Hernandez-Rodriguez I; Gonzalez-Gay MA Arthritis Rheum; 2005 Dec; 53(6):931-8. PubMed ID: 16342107 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Polymyalgia Rheumatica 2000-2014 and Examination of Incidence and Survival Trends Over 45 Years: A Population-Based Study. Raheel S; Shbeeb I; Crowson CS; Matteson EL Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1282-1285. PubMed ID: 27768840 [TBL] [Abstract][Full Text] [Related]
16. Mortality Among Patients With Polymyalgia Rheumatica: A Retrospective Cohort Study. Partington R; Muller S; Mallen CD; Abdul Sultan A; Helliwell T Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1853-1857. PubMed ID: 32741132 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Maradit Kremers H; Reinalda MS; Crowson CS; Davis JM; Hunder GG; Gabriel SE Arthritis Rheum; 2007 Mar; 57(2):279-86. PubMed ID: 17330277 [TBL] [Abstract][Full Text] [Related]
18. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study. Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315 [TBL] [Abstract][Full Text] [Related]
19. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051 [TBL] [Abstract][Full Text] [Related]